Rare Blood

Latest News

What We’re Reading: Sickle Cell Cure Complexity; Free Care for Veterans in Suicidal Crisis; Pfizer to Offer Low-Cost Drugs to Underserved Countries
What We’re Reading: Sickle Cell Cure Complexity; Free Care for Veterans in Suicidal Crisis; Pfizer to Offer Low-Cost Drugs to Underserved Countries

January 17th 2023

The reality of a sickle cell disease cure brings fear, optimism, and questions to patients’ lives; veterans who are in suicidal crisis can receive free emergency care at any Department of Veterans Affairs or private facility; Pfizer to increase access to progressive treatments through sale of drugs at non-profit prices to poor countries.

 Top 5 Most-Read Rare Blood Content of 2022
Top 5 Most-Read Rare Blood Content of 2022

December 22nd 2022

Conquering SCD by Confronting Treatment Barriers, Investigating PROs
Conquering SCD by Confronting Treatment Barriers, Investigating PROs

December 22nd 2022

Analysis of Beti-Cel for Severe β-Thalassemia Shows Extensive, Long-term Patient Improvement
Analysis of Beti-Cel for Severe β-Thalassemia Shows Extensive, Long-term Patient Improvement

December 20th 2022

Phase 3 CADENZA Trial Validates QOL Improvements Reported by Patients With CAD Receiving Sutimlimab
Phase 3 CADENZA Trial Validates QOL Improvements Reported by Patients With CAD Receiving Sutimlimab

December 9th 2022

More News

© 2023 MJH Life Sciences
AJMC®
All rights reserved.